# A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

Study · id `cardio:ct-nct07359807` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07359807](<https://clinicaltrials.gov/study/NCT07359807>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07359807

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 478 participants.

## Technical summary

Registry record NCT07359807. Randomized; double masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 478 participants (planned count; ClinicalTrials.gov record NCT07359807, source copy `cardio:ctgov-nct07359807-2026-04-17`, retrieved 2026-10-31)
- Planned start: 2026-04 (anticipated) (ClinicalTrials.gov record NCT07359807, source copy `cardio:ctgov-nct07359807-2026-04-17`, retrieved 2026-10-31)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07359807, source copy `cardio:ctgov-nct07359807-2026-04-17`, retrieved 2026-10-31)
- Completion: 2033-01 (anticipated) (ClinicalTrials.gov record NCT07359807, source copy `cardio:ctgov-nct07359807-2026-04-17`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07359807-2026-04-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
- Acronym: MAGICAL SFA
- Condition: Popliteal Artery Disease
- Condition: Superficial Femoral Artery Disease
- Intervention (Combination product): Sirolimus (RAPAMUNE) drug-coated balloon angioplasty catheter
- Intervention (Combination product): Paclitaxel drug-coated balloon angioplasty
- Lead sponsor: Concept Medical Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Concept Medical Inc. (`cardio:org-concept-medical-inc`)

## Provenance

Content hash: 89d1b324630a808c4155a987021cc1b1ec781a246ff0fc49b8f4a3a6e4432c80
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
